Mon, Dec 22, 2014, 12:59 AM EST - U.S. Markets open in 8 hrs 31 mins

Recent

% | $
Quotes you view appear here for quick access.

Accelerate Diagnostics, Inc. Message Board

  • nyctel nyctel Aug 20, 2011 8:43 AM Flag

    Reasons to invest in Accelr8 Technology

    Despite the drug resistance crisis, virtually all bacterial and fungal infections can still be treated successfully with an existing antibiotic. The problem is finding one that works in the very limited time within which treatment must begin in order to make a difference.

    The problem with resistance is that the lab takes too long to identify it. As a result, the doc has no choice but to guess. They either use the "standard" drug or a broad-spectrum combination that works for the majority of cases. But this majority is now down to about two-thirds. This means that one-third of cases, on the average, now fail even with a combination of broad-spectrum drugs. They just turn out to be the wrong choices for a specific patient's strains.

    Therefore a fast method to identify the few drugs that should work -- often down to one or two particular drugs -- is what the hospital needs.

    The scary stories in the news media fail to emphasize this critical point. You can still treat almost everything. The question is what drug to use. There are no universally successful drugs, and the list of choices is shrinking fast.

    That's why we diagnosticians get excited about new technology. We KNOW there is a drug that will work, we just can't find it fast enough.

    Ask other lab people and docs that specialize in these cases.

    This is why AXK is so freaking exciting.

    thank dx

 
AXDX
17.94-0.31(-1.70%)Dec 19 4:00 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.